Eli Lilly and Company announced plans to invest more than $1 billion over the next several years into new contract manufacturing in India, expanding patients’ access to innovative medicines around the world. In addition, Lilly will establish a new Manufacturing & Quality presence in Hyderabad. This new hub will offer advanced technical capabilities and oversight for Lilly’s contract manufacturing network across India. Recruitment will begin immediately.